Caseware UK (AP4) 2023.0.135 2023.0.135 2024-02-292024-02-29The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false2023-03-01falseABC33falsetrue 13210909 2023-03-01 2024-02-29 13210909 2022-03-01 2023-02-28 13210909 2024-02-29 13210909 2023-02-28 13210909 c:Director3 2023-03-01 2024-02-29 13210909 d:PatentsTrademarksLicencesConcessionsSimilar 2024-02-29 13210909 d:PatentsTrademarksLicencesConcessionsSimilar 2023-02-28 13210909 d:CurrentFinancialInstruments 2024-02-29 13210909 d:CurrentFinancialInstruments 2023-02-28 13210909 d:CurrentFinancialInstruments d:WithinOneYear 2024-02-29 13210909 d:CurrentFinancialInstruments d:WithinOneYear 2023-02-28 13210909 d:ShareCapital 2024-02-29 13210909 d:ShareCapital 2023-02-28 13210909 d:SharePremium 2024-02-29 13210909 d:SharePremium 2023-02-28 13210909 d:RetainedEarningsAccumulatedLosses 2024-02-29 13210909 d:RetainedEarningsAccumulatedLosses 2023-02-28 13210909 c:OrdinaryShareClass1 2023-03-01 2024-02-29 13210909 c:OrdinaryShareClass1 2024-02-29 13210909 c:OrdinaryShareClass1 2023-02-28 13210909 c:FRS102 2023-03-01 2024-02-29 13210909 c:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-29 13210909 c:FullAccounts 2023-03-01 2024-02-29 13210909 c:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 13210909 d:PatentsTrademarksLicencesConcessionsSimilar d:ExternallyAcquiredIntangibleAssets 2023-03-01 2024-02-29 13210909 2 2023-03-01 2024-02-29 13210909 d:PatentsTrademarksLicencesConcessionsSimilar d:OwnedIntangibleAssets 2023-03-01 2024-02-29 13210909 e:PoundSterling 2023-03-01 2024-02-29 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 13210909









EVOKE ORGANICS LIMITED







UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 29 FEBRUARY 2024

 
EVOKE ORGANICS LIMITED
REGISTERED NUMBER: 13210909

BALANCE SHEET
AS AT 29 FEBRUARY 2024

2024
2023
Note
£
£

Fixed assets
  

Intangible assets
 4 
4,053
4,159

Current assets
  

Stocks
 5 
74,120
101,239

Debtors: amounts falling due within one year
 6 
3,713
8,884

Cash at bank and in hand
 7 
1,155
35,324

  
78,988
145,447

Creditors: amounts falling due within one year
 8 
(9,221)
(6,382)

Net current assets
  
 
 
69,767
 
 
139,065

  

Net assets
  
73,820
143,224


Capital and reserves
  

Called up share capital 
 9 
50
47

Share premium account
  
230,105
205,166

Profit and loss account
  
(156,335)
(61,989)

  
73,820
143,224


Page 1

 
EVOKE ORGANICS LIMITED
REGISTERED NUMBER: 13210909
    
BALANCE SHEET (CONTINUED)
AS AT 29 FEBRUARY 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 27 November 2024.




N S Yap
Director

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
EVOKE ORGANICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024

1.


General information

Evoke Organics Limited ("the Company") is a private company limited by shares, incorporated in England and Wales. Its registered office is Leytonstone House, 3 Hanbury Drive, Leytonstone, London E11 1GA.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of comprehensive income within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

Page 3

 
EVOKE ORGANICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024

2.Accounting policies (continued)

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

 
2.4

Interest income

Interest income is recognised in the Statement of income and retained earnings using the effective interest method.

 
2.5

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.6

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in the Statement of income and retained earnings.

 
2.7

Debtors

Short-term debtors are measured at transaction price, less any impairment.

 
2.8

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.

Page 4

 
EVOKE ORGANICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024

2.Accounting policies (continued)

 
2.9

Creditors

Short-term creditors are measured at the transaction price.

 
2.10

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.


3.


Employees

The average monthly number of employees, including directors, during the year was 3 (2023 - 3).


4.


Intangible assets






Trademark

£



Cost


At 1 March 2023
4,984


Additions
428



At 29 February 2024

5,412



Amortisation


At 1 March 2023
825


Charge for the year on owned assets
534



At 29 February 2024

1,359



Net book value



At 29 February 2024
4,053



At 28 February 2023
4,159



Page 5

 
EVOKE ORGANICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024

5.


Stocks

2024
2023
£
£

Raw materials and consumables
74,120
101,239



6.


Debtors

2024
2023
£
£


Trade debtors
28
-

Other debtors
3,685
8,884

3,713
8,884



7.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
1,155
35,324



8.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
6,118
4,782

Other creditors
1,503
-

Accruals and deferred income
1,600
1,600

9,221
6,382


Page 6

 
EVOKE ORGANICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 29 FEBRUARY 2024

9.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



4,987 (2023 - 4,706) Ordinary shares of £0.01 each
49.87
47.06


During the year, a further 281 Ordinary shares of £0.01 each were issued at a premium.


10.


Related party transactions

Included within other creditors due within one year is an amount of £1,503 (2023 - £Nil) owed to the directors of the Company.

 
Page 7